Famotidine (oral)

Revision as of 14:21, 14 January 2015 by Kiran Singh (talk | contribs)
Jump to navigation Jump to search

{{DrugProjectFormSinglePage |authorTag=Kiran Singh, M.D. [1] |genericName=famotidine |aOrAn=a |drugClass=gastric acid secretion inhibitor |indicationType=treatment |indication=heartburn,gastric hypersecretion, gastric ulcer,gastroesophageal reflux, indigestion |adverseReactions=constipation ,[[diarrhea, dizziness , headache |blackBoxWarningTitle=ConditionName: |blackBoxWarningBody=ConditionName:

  • Content


|fdaLIADAdult===Indications==

Dosing

  • To relieve symptoms, swallow 1 tablet with a glass of water. Do not chew.
  • To prevent symptoms, swallow 1 tablet with a glass of water at any time from 10 to 60 minutes before eating food or drinking beverages that cause heartburn
  • Do not use more than 2 tablets in 24 hours

|offLabelAdultGuideSupport=There is limited information regarding Off-Label Guideline-Supported Use of famotidine in adult patients. |offLabelAdultNoGuideSupport===Indications==

Dosing

  • Duodenal ulcer disease: acute, 40 mg ORALLY once daily at bedtime or 20 mg ORALLY twice daily
  • Duodenal ulcer disease: maintenance, 20 mg ORALLY once daily at bedtime
  • Esophagitis - Gastroesophageal reflux disease, Short term treatment: 20 to 40 mg ORALLY twice daily for up to 12 weeks
  • Esophagitis - Gastroesophageal reflux disease, Short term treatment: 20 mg IV every 12 hours
  • Gastric hypersecretion: 20 to 160 mg ORALLY every 6 h.
  • Gastric hypersecretion: 20 mg IV every 12 h
  • Gastric ulcer, Short term treatment: acute, 40 mg ORALLY once daily at bedtime
  • Gastric ulcer, Short term treatment: acute, 20 mg IV every 12 h
  • Gastroesophageal reflux disease, Short-term, symptom treatment: 20 mg ORALLY twice daily for up to 6 wks
  • Gastroesophageal reflux disease, Short-term, symptom treatment: 20 mg IV every 12 hours

Indigestion: 10 to 20 mg ORALLY twice daily |fdaLIADPed===Indication==

Dosing

Children 12 years and over:

To relieve symptoms, swallow 1 tablet with a glass of water. Do not chew.

  • To prevent symptoms, swallow 1 tablet with a glass of water at any time from 10 to 60 minutes before eating food or drinking beverages that cause heartburn
  • Do not use more than 2 tablets in 24 hours

Children under 12 years: ask a doctor |offLabelPedGuideSupport=There is limited information regarding Off-Label Guideline-Supported Use of Famotidine in pediatric patients. |offLabelPedNoGuideSupport===Indications==

Dosage

  • Duodenal ulcer disease: (over 1 y old) 0.5 mg/kg/day ORALLY at bedtime or divided twice daily; MAX dose 40 mg/day
  • Duodenal ulcer disease: (over 1 y old) 0.25 to 0.5 mg/kg IV every 12 h; MAX dose 40 mg/day
  • Gastric ulcer, Short term treatment: (over 1 y old) 0.5 mg/kg/day ORALLY at bedtime or divided twice daily; MAX dose 40 mg/day
  • Gastric ulcer, Short term treatment: (over 1 y old) 0.25 to 0.5 mg/kg IV every 12 h; MAX dose 40 mg/day

|warnings=Allergy alert: Do not use if you are allergic to famotidine or other acid reducers

Do not use

if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor. if you have kidney disease, except under the advice and supervision of a doctor with other acid reducers

Ask a doctor before use if you have

  • Had heartburn over 3 months. This may be a sign of a more serious condition.
  • Frequent chest pain
  • Frequent wheezing, particularly with heartburn
  • Unexplained weight loss

Stop use and ask a doctor if

  • Your heartburn continues or worsens
  • You need to take this product for more than 14 days

If pregnant or breast-feeding,

  • Ask a health professional before use.

Keep out of reach of children.

  • In case of overdose, get medical help or contact a Poison Control Center right away.

|clinicalTrials=Common

Serious

|postmarketing=There is limited information regarding Postmarketing Experience of Famotidine (oral) in the drug label. |useInPregnancyAUS=* Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Famotidine in women who are pregnant. |useInLaborDelivery=There is no FDA guidance on use of Famotidine during labor and delivery. |useInNursing=There is no FDA guidance on the use of Famotidine with respect to nursing mothers. |useInPed=There is no FDA guidance on the use of Famotidine with respect to pediatric patients. |useInGeri=There is no FDA guidance on the use of Famotidine with respect to geriatric patients. |useInGender=There is no FDA guidance on the use of Famotidine with respect to specific gender populations. |useInRace=There is no FDA guidance on the use of Famotidine with respect to specific racial populations. |useInRenalImpair=There is no FDA guidance on the use of Famotidine in patients with renal impairment. |useInHepaticImpair=There is no FDA guidance on the use of Famotidine in patients with hepatic impairment. |useInReproPotential=There is no FDA guidance on the use of Famotidine in women of reproductive potentials and males. |useInImmunocomp=There is no FDA guidance one the use of Famotidine in patients who are immunocompromised. |administration=* Oral |monitoring=There is limited information regarding Monitoring of Famotidine in the drug label.


|IVCompat=There is limited information regarding IV Compatibility of Famotidine in the drug label. |overdose=There is limited information regarding Chronic Overdose of Famotidine in the drug label.

|drugBox=

This image is provided by the National Library of Medicine.

|mechAction=* |PD=There is limited information regarding Pharmacodynamics of in the drug label. |PK=There is limited information regarding Pharmacokinetics of Famotidine in the drug label. |nonClinToxic=There is limited information regarding Nonclinical Toxicology of Famotidine in the drug label. |clinicalStudies=There is limited information regarding Clinical Studies of Famotidine in the drug label. |howSupplied=* |storage=* Store at 20°-25°C (68°-77°F)

  • Protect from moisture and light

|fdaPatientInfo=There is limited information regarding Patient Counseling Information of Famotidine in the drug label. |alcohol=* Alcohol-Famotidine interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication. |brandNames=* 7 SELECT ACID CONTROLLER |drugShortage= }} {{#subobject: 

 |Page Name=Famotidine (oral)
 |Pill Name=No image.jpg
 |Drug Name=
 |Pill Ingred=|+sep=;
 |Pill Imprint=
 |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}}
 |Pill Color=|+sep=;
 |Pill Shape=
 |Pill Size (mm)=
 |Pill Scoring=
 |Pill Image=
 |Drug Author=
 |NDC=

}}

{{#subobject: 

 |Label Page=Famotidine (oral)
 |Label Name=Famotidine fig01.jpg

}}

{{#subobject: 

 |Label Page=Famotidine (oral)
 |Label Name=Famotidine ingredients and appearance.png

}}

{{#subobject: 

 |Label Page=Famotidine (oral)
 |Label Name=Famotidine fig.jpg

}}

Retrieved from "https://www.wikidoc.org/index.php?title=Famotidine_(oral)&oldid=1054597"